Life sciences and real estate to advance Blackstone’s $150bn fundraising goal

While capital raising across strategies 'tends to ebb and flow, the overall path of travel is towards more alternatives', says Blackstone’s president and COO.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.